Results for Pediatric Endocrinology

1 - 10 of 84

Dr. Weber is a clinical researcher focused on improving bone health in children. He is currently focused on investigating the effects of effects of type 1 diabetes and Duchenne muscular dystrophy on the skeleton.

E-mail:

weberd [at] chop.edu

Andrea Kelly, MD, MSCE

Dr. Kelly is an attending physician in the Division of Endocrinology and Diabetes at Children's Hospital of Philadelphia and a professor of pediatrics at the University of Pennsylvania. Her research focuses on cystic fibrosis, bone and body composition, and endocrine co-morbidities in Down syndrome.

E-mail:

kellya [at] chop.edu

Sogol Mostoufi-Moab, MD, MSCE

Dr. Mostoufi-Moab's clinical and research program is focused on endocrine late effects after childhood cancer therapy. She has unique dual training in pediatric endocrinology and oncology with a master's degree in clinical epidemiology. The goal of her research program is to pursue a mechanistic understanding of metabolic and endocrine disorders that occur due to cancer therapy.

E-mail:

moab [at] chop.edu

Adda Grimberg, MD

Dr. Grimberg investigates the growth hormone (GH)/insulin-like growth factor (IGF)-I axis and clinical issues related to child growth. Her recent research is focused on disparities in, and the decision-making related to, the medical management of children with short stature. She is fascinated by how differential societal pressures for tallness and the advent of an expensive therapeutic have transformed a fundamental aspect of pediatric healthcare.

E-mail:

grimberg [at] chop.edu

Michael A. Levine, MD, FAAP, FACP, MACE

Dr. Levine has an active laboratory research program that complements and extends his clinical studies. He has identified the molecular basis of several inherited disorders of mineral metabolism. His research interests extend to the molecular basis for embryological development of the parathyroid glands.

E-mail:

levinem [at] chop.edu

Jeffrey D. Roizen, MD, PhD, FAAP

Dr. Roizen's research program aims to understand non-calciometabolic effects of vitamin D and to use this understanding to design new therapeutic approaches to common diseases such as sarcopenia and obesity.

E-mail:

roizenj [at] chop.edu

Katherine Lord, MD

Dr. Lord's research focuses on congenital hyperinsulinism, a rare disorder resulting in severe hypoglycemia at birth.

E-mail:

lordk [at] chop.edu

Charles A. Stanley, MD

Dr. Stanley’s lab has identified many of the genes and syndromes associated with congenital hyperinsulinism including ABCC8, GCK, GLUD1, and Turner and Beckwith syndromes. Working with clinical and rodent model studies, his lab team has identified distinctive phenotypes of these disorders, including diazoxide unresponsiveness, leucine sensitivity, and protein sensitivity. Dr. Stanley continues to seek new diagnostic and treatment paradigms for infants with acquired and genetic disorders of hyperinsulinism.

E-mail:

stanleyc [at] chop.edu

Andrew J. Bauer, MD

Dr. Bauer's academic and clinical career are focused on improving the care of children and adolescents with thyroid disease. He has extensive experience and knowledge of thyroid pathophysiology and tumorigenesis, and has been critical to the clinical success of the Children's Hospital of Philadelphia Thyroid Center.

E-mail:

bauera [at] chop.edu

Karla F. Leavens, MD, PhD

Dr. Leavens uses stem cell-derived beta cells to model pediatric beta cell disease, including monogenic diabetes and congenital hyperinsulinism. The goal of her studies is to better understand and develop novel therapeutics to treat these diseases.

E-mail:

leavensk [at] chop.edu